Ian O. Ellis
Cancer Research · 2004–2020
A researcher in the Science corpus: 15 papers; trusts 1 researcher and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Cancer Research — 167 citations into it; #916 of 1,780 by trust here, #303 by citations
Whom Ian O. Ellis trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Charles M. Perou (in Cancer Research)
Who trusts Ian O. Ellis
- J. Reis-Filho (in Cancer Research)
- Karel G. M. Moons (in Cancer Research)
- Douglas G. Altman (in Cancer Research)
Papers from Ian O. Ellis's perspective
Ordered by how strongly the researchers Ian O. Ellis trusts endorse each paper. Same corpus, a different order for every researcher.
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications (Proceedings of the National Academy of Sciences of the United States of America)
- Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma (Clinical Cancer Research)
- Re: Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer
- Breast cancer classification and prognosis based on gene expression profiles from a population-based study (Proceedings of the National Academy of Sciences of the United States of America)
- A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. (New England Journal of Medicine)
- Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. (Journal of the American Medical Association (JAMA))
- Expert Commentary. (Histopathology)
- Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. (Cancer Research)
- Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma (Nature)
- Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. (Journal of the National Cancer Institute)
Their papers
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups (2012) — 5,719 citations
- MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype (2007) — 1,015 citations
- The 2019 World Health Organization classification of tumours of the breast (2020) — 846 citations
- Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. (2018) — 1,382 citations
- The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes (2016) — 1,612 citations
- Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients. (2014) — 723 citations
- Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer. (2011) — 724 citations
- Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists (2011) — 704 citations
- Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. (2011) — 1,221 citations
- Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies (2010) — 1,105 citations
- Breast cancer prognostic classification in the molecular era: the role of histological grade (2010) — 954 citations
- Basal-like breast cancer: a critical review. (2008) — 953 citations
- Prognostic markers in triple‐negative breast cancer (2007) — 1,326 citations
- The Nottingham prognostic index in primary breast cancer (2005) — 947 citations
- Expression of luminal and basal cytokeratins in human breast carcinoma (2004) — 615 citations